Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fatty acyl-CoA reductase 2 pseudogene 2 (FAR2P2) is an annotated pseudogene related to the fatty acyl-CoA reductase family, specifically resembling fatty acyl-CoA reductase 2 (FAR2), which functions as a reductase enzyme in lipid metabolism. Pseudogenes such as FAR2P2 do not produce functional proteins; they arise from gene duplication or retrotransposition events and typically lack biological activity, though some pseudogenes can have regulatory roles. There is no evidence indicating molecular function, tissue specificity, therapeutic target status, or disease relevance for FAR2P2[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fatty acyl-CoA reductase 2 pseudogene 2 (FAR2P2).